* Review of Chronic Lymphocytic Leukemia (CLL), in the Context of COVID-19 & Its Variants
* Significant Role of Testing in Informing Your Treatment Choices
* First Line Treatment Options
* Treatment of Relapsed & Refractory CLL
* Re-Testing Importance in Determining Treatment for 2nd & 3rd Line Treatments
* Current Perspectives on New & Emerging Treatments of CLL
* Updates on Clinical Trials & Their Significance for CLL
* Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of OpenNotes
* Practical Support to Cope with CLL
* Questions for Our Panel of Experts